Skip to main content
Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
40.48
-0.52 (-1.27%)
At close: Nov 13, 2026, 4:00 PM EST
39.69
-0.79 (-1.95%)
After-hours: Nov 13, 2026, 7:51 PM EST

Xenon Pharmaceuticals Revenue

In the year 2025, Xenon Pharmaceuticals had annual revenue of $7.50M. That makes Xenon Pharmaceuticals the 38,585th largest company in the world by revenue and 5,070th in the United States.

Revenue (ttm)
$7.50M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
370
Market Cap
3.98B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.50M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20229.43M-9.00M-48.83%
Dec 31, 202118.44M-13.73M-42.68%
Dec 31, 202032.17M25.34M371.02%
Dec 31, 20196.83M--
Dec 31, 2018---
Dec 31, 2017311.00K-1.49M-82.75%
Dec 31, 20161.80M-13.77M-88.43%
Dec 31, 201515.58M-12.79M-45.09%
Dec 31, 201428.37M1.01M3.71%
Dec 31, 201327.36M13.05M91.19%
Dec 31, 201214.31M7.39M106.82%
Dec 31, 20116.92M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Legend Biotech1.36B
Ionis Pharmaceuticals960.09M
Tarsus Pharmaceuticals682.20M
Iovance Biotherapeutics378.98M
AbCellera Biologics67.85M
Tango Therapeutics53.81M
CRISPR Therapeutics AG25.17M
Relay Therapeutics10.35M
Revenue Rankings

XENE News

More News